StonvexLoading…
StonvexStonvexStonvexCore line items from SGHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.70M | $77.36M | $56.98M | $37.07M |
Operating Income | $-12.41M | $-37.10M | $-33.43M | $-25.53M |
Net Income | $-12.98M | $-38.43M | $-34.26M | $-26.09M |
EPS (Diluted) | $-0.24 | $-0.74 | $-0.66 | $-0.51 |
Total Assets | $109.70M | $115.30M | $116.26M | $121.97M |
Total Liabilities | $55.80M | $51.36M | $51.97M | $51.96M |
Cash & Equivalents | $84.96M | $91.97M | $92.37M | $101.50M |
Free Cash Flow OCF − CapEx | $-7.09M | $-29.92M | $-28.25M | $-19.36M |
Shares Outstanding | 54.03M | 53.49M | 52.47M | 52.03M |